Tea Polyphenols Modulate Antioxidant Redox System on Cisplatin-induced Reactive Oxygen Species Generation in a Human Breast Cancer Cell
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tea Polyphenols Modulate Antioxidant Redox System on Cisplatin-induced Reactive Oxygen Species Generation in a Human Breast Cancer Cell
Authors
Keywords
-
Journal
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Volume 112, Issue 6, Pages 374-384
Publisher
Wiley
Online
2013-05-20
DOI
10.1111/bcpt.12035
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Modification and Implementation of NCCN Guidelines™ on Breast Cancer in the Middle East and North Africa Region
- (2017) Omalkhair Abulkhair et al. Journal of the National Comprehensive Cancer Network
- Mitochondrial oxidative stress drives tumor progression and metastasis: should we use antioxidants as a key component of cancer treatment and prevention?
- (2011) Federica Sotgia et al. BMC Medicine
- Significant changes in dietary intake and supplement use after breast cancer diagnosis in a UK multicentre study
- (2011) Louiza S. Velentzis et al. BREAST CANCER RESEARCH AND TREATMENT
- Effect of vitamins C and E on antioxidant status of breast-cancer patients undergoing chemotherapy
- (2011) N. Suhail et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Tea catechins and their applications as supplements and pharmaceutics
- (2011) Yukihiko Hara PHARMACOLOGICAL RESEARCH
- Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy
- (2011) Hiroshi Yagata et al. Breast Cancer
- (–)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells
- (2010) Fulvia Farabegoli et al. BIOSCIENCE REPORTS
- Individual responses to chemotherapy-induced oxidative stress
- (2010) Dora Il’yasova et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer
- (2010) Yen-Shen Lu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pituitary Adenylate Cyclase-Activating Polypeptide Prevents Cisplatin-Induced Renal Failure
- (2010) Min Li et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Mitochondrial/lysosomal toxic cross-talk plays a key role in cisplatin nephrotoxicity
- (2010) Jalal Pourahmad et al. XENOBIOTICA
- The p53 tumor suppressor network in cancer and the therapeutic modulation of cell death
- (2009) Nikhil S. Chari et al. APOPTOSIS
- Mode of cytotoxic action of nephrotoxic agents: oxidative stress and glutathione-dependent enzyme
- (2009) Brandon Louie et al. BJU INTERNATIONAL
- Mutant p53 mediates survival of breast cancer cells
- (2009) L Y Lim et al. BRITISH JOURNAL OF CANCER
- Platinum-based chemotherapy in triple-negative breast cancer
- (2008) B. Sirohi et al. ANNALS OF ONCOLOGY
- Vitamin C Antagonizes the Cytotoxic Effects of Antineoplastic Drugs
- (2008) M. L. Heaney et al. CANCER RESEARCH
- The present and the future of breast cancer burden in the Kingdom of Saudi Arabia
- (2008) Ezzeldin M. Ibrahim et al. MEDICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started